• Citer

Venlafaxine compared with fluoxetine in outpatients with depression and concomitant anxiety.

par De Nayer, Andre;Geerts, Stefaan;Ruelens, Leo;Schittecatte, Michel ;De Bleeker, Eugeen;Van Eeckhoutte, Ignace;Evrard, Jean-Luc;Linkowski, Paul ;Fossion, Pierre ;Leyman, Sophie;Mignon, Annick
Référence International journal of neuropsychopharmacology, 5, 2, page (115-120)
Publication Publié, 2002-06

Article révisé par les pairs

• Accès en ligne
• Détails
• Contenu
• Statistiques

Titre:	Venlafaxine compared with fluoxetine in outpatients with depression and concomitant anxiety.
Auteur:	De Nayer, Andre; Geerts, Stefaan; Ruelens, Leo; Schittecatte, Michel; De Bleeker, Eugeen; Van Eeckhoutte, Ignace; Evrard, Jean-Luc; Linkowski, Paul; Fossion, Pierre; Leyman, Sophie; Mignon, Annick
Informations sur la publication:	International journal of neuropsychopharmacology, 5, 2, page (115-120)
Statut de publication:	Publié, 2002-06
Sujet CREF:	Sciences bio-médicales et agricoles
Mots-clés:	Concomitant anxiety
	Depression
	Fluoxetine
	Venlafaxine
MeSH keywords:	Adolescent
	Adult
	Aged
	Antidepressive Agents, Second-Generation -- adverse effects
	Antidepressive Agents, Second-Generation -- therapeutic use
	Anxiety Disorders -- complications
	Anxiety Disorders -- drug therapy
	Anxiety Disorders -- psychology
	Belgium
	Cyclohexanols -- adverse effects
	Cyclohexanols -- therapeutic use
	Depressive Disorder -- complications
	Depressive Disorder -- drug therapy
	Depressive Disorder -- psychology
	Double-Blind Method
	Female
	Fluoxetine -- adverse effects
	Fluoxetine -- therapeutic use
	Humans
	Male
	Middle Aged
	Outpatients
	Psychiatric Status Rating Scales
Note générale:	Clinical Trial
	Clinical Trial, Phase IV
	Comparative Study
	Journal Article
	Multicenter Study
	Randomized Controlled Trial
	SCOPUS: ar.j
Langue:	Anglais
Identificateurs:	urn:issn:1461-1457
	info:doi/10.1017/S1461145702002857
	info:pii/S1461145702002857
	info:scp/6444245490
	info:pmid/12135535